Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Erlotinib Hydrochloride × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hereditary leiomyomatosis and renal cell cancer 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

pembrolizumab 9 Cisplatin 7 Radiotherapy 5 Carboplatin 5 Human Papillomavirus DNA Tests 4 Gemcitabine 4 Fulvestrant 4 Bevacizumab 4 zimberelimab 3 tisotumab vedotin 3 Specimen Handling 3 Restraint, Physical 3 Paclitaxel 3 Magnetic Resonance Spectroscopy 3 Colposcopy 3 Brachytherapy 3 spartalizumab 2 lenvatinib 2 Vinorelbine 2 Topotecan 2 Radiation 2 Platinum 2 Pemetrexed 2 Nivolumab 2 Irinotecan 2 Drug Therapy 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 trastuzumab deruxtecan 1 toripalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡